1. |
中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版). 中华消化外科杂志, 2024, 23(4): 429-478.
|
2. |
冯凯, 马宽生, 别平. 射频消融在肝细胞肝癌根治性治疗中的临床价值. 中国普外基础与临床杂志, 2014, 21(2): 150-155.
|
3. |
Xu XL, Liu XD, Liang M, et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Radiology, 2018, 287(2): 461-472.
|
4. |
董家鸿, 张宁. 精准外科. 中华外科杂志, 2015, 53(5): 321-323.
|
5. |
樊嘉, 高强. 肝癌诊疗新进展: 指南引领规范创新赋能精准. 中华消化外科杂志, 2024, 23(2): 197-203.
|
6. |
Li C, Wang Q, Zou M, et al. A radiomics model based on preoperative gadoxetic acid-enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma. Front Oncol, 2023, 13: 1164739. doi: 10.3389/fonc.2023.1164739.
|
7. |
蒋涵羽, 陈卫霞. 浅析肝脏影像报告及数据系统在肝细胞癌诊治中的关键应用及挑战. 中国普外基础与临床杂志, 2024, 31(3): 272-277.
|
8. |
Jiang YQ, Wang ZX, Deng YN, et al. Efficacy of hepatic resection vs. radiofrequency ablation for patients with very-early-stage or early-stage hepatocellular carcinoma: A population-based study with stratification by age and tumor size. Front Oncol, 2019, 9: 113. doi: 10.3389/fonc.2019.00113.
|
9. |
Zhang K, Jiang L, Jia Z, et al. Radiofrequency ablation plus devascularization is the preferred treatment of hepatocellular carcinoma with esophageal varices. Dig Dis Sci, 2015, 60(5): 1490-1501.
|
10. |
Vibert E, Schwartz M, Olthoff KM. Advances in resection and transplantation for hepatocellular carcinoma. J Hepatol, 2020, 72(2): 262-276.
|
11. |
盛思满, 陈闯, 陈小宇, 等. 钆塞酸二钠增强磁共振成像在肝细胞癌大体形态分型中的应用价值. 中国普外基础与临床杂志, 2023, 30(7): 814-819.
|
12. |
Liu J, Guo Y, Sun Y, et al. Three-dimensional ultrasound fusion imaging in precise needle placement for thermal ablation of hepatocellular carcinoma. Int J Hyperthermia, 2024, 41(1): 2316097. doi: 10.1080/02656736.2024.2316097.
|
13. |
Shindoh J, Makuuchi M, Matsuyama Y, et al. Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma. J Hepatol, 2016, 64(3): 594-600.
|
14. |
杨世忠, 冯晓彬, 董家鸿. 精准外科理念指导下的肝癌外科治疗. 精准医学杂志, 2018, 33(3): 189-192,196.
|
15. |
李璟寰, 王艳红. 射频消融治疗肝癌研究概况. 中华临床医师杂志(电子版), 2013, 7(8): 3526-3530.
|
16. |
Ikeda K, Osaki Y, Nakanishi H, et al. Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma. Oncology, 2014, 87 Suppl 1: 73-77.
|
17. |
周俭, 樊嘉, 肖永胜. 肝细胞癌门静脉癌栓形成机制. 实用肿瘤杂志, 2009, 24(5): 425-428.
|
18. |
Xu EJ, Lv SM, Li K, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. Int J Hyperthermia, 2018, 34(6): 870-876.
|
19. |
蔡建强, 赵宏, 陈晓. 肝癌综合治疗新格局. 中华消化外科杂志, 2024, 23(2): 204-208.
|
20. |
Wang X, Liu G, Chen S, et al. Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis. Int J Hyperthermia, 2021, 38(1): 1519-1528.
|
21. |
Cheng AL, Hsu C, Chan SL, et al. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol, 2020, 72(2): 307-319.
|
22. |
Pinter M, Jain RK, Duda DG. The current landscape of immune checkpoint blockade in hepatocellular carcinoma: a review. JAMA Oncol, 2021, 7(1): 113-123.
|
23. |
Feng X, Xu R, Du X, et al. Combination therapy with sorafenib and radiofrequency ablation for BCLC stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study. Am J Gastroenterol, 2014, 109(12): 1891-1899.
|
24. |
Kudo M. Recent advances in systemic therapy for hepatocellular carcinoma in an aging society: 2020 update. Liver Cancer, 2020, 9(6): 640-662.
|
25. |
中华医学会超声医学分会介入诊疗学组, 中国医药教育协会介入微创治疗专委会纳米刀肿瘤消融学会. 超声引导肝癌不可逆电穿孔消融治疗临床实践指南(2023版). 中华超声影像学杂志, 2023, 32(12): 1013-1020.
|